(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide hydrochloride(1:x)
97%
- Product Code: 113840
CAS:
1254955-21-9
| Molecular Weight: | 522.40 g./mol | Molecular Formula: | C₂₄H₂₆Cl₂FN₅O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30342454 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, stored under inert gas |
Product Description:
This chemical is primarily used in the development of targeted cancer therapies. It functions as a potent inhibitor of specific tyrosine kinases, which are enzymes involved in the signaling pathways that promote cancer cell growth and survival. By blocking these kinases, it helps to halt the proliferation of cancer cells and can induce apoptosis, or programmed cell death. Its application is particularly relevant in treating non-small cell lung cancer (NSCLC) and other solid tumors where the targeted kinases are overactive. The compound is often incorporated into pharmaceutical formulations designed for oral administration, ensuring effective delivery to the affected tissues. Ongoing research continues to explore its potential in combination therapies and its efficacy against resistant forms of cancer.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | €73.37 |
+
-
|
| 0.250 | 10-20 days | €146.74 |
+
-
|
(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide hydrochloride(1:x)
This chemical is primarily used in the development of targeted cancer therapies. It functions as a potent inhibitor of specific tyrosine kinases, which are enzymes involved in the signaling pathways that promote cancer cell growth and survival. By blocking these kinases, it helps to halt the proliferation of cancer cells and can induce apoptosis, or programmed cell death. Its application is particularly relevant in treating non-small cell lung cancer (NSCLC) and other solid tumors where the targeted kinases are overactive. The compound is often incorporated into pharmaceutical formulations designed for oral administration, ensuring effective delivery to the affected tissues. Ongoing research continues to explore its potential in combination therapies and its efficacy against resistant forms of cancer.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :